Australia and New Zealand Banking Group Ltd. — Capital/Financing Update 2008

Sep 17, 2008

RELEASE

==> picture [128 x 78] intentionally omitted <==

18 September 2008

ASX: SIP

SIGMA REFINANCES ALL CORPORATE DEBT FACILITIES

Sigma Pharmaceuticals Limited (Sigma) today announced that it has successfully refinanced all of its corporate debt facilities.

The new facilities incorporate a new $500 million syndicated debt facility, an extension of the $100 million Waratah trade receivables program to February 2010, and an increase of $100 million in the off-balance sheet Sigma Rewards securitisation program that is in place until March 2011.

The joint lead arrangers of the new $500 million syndicated debt facility are Australia and New Zealand Banking Group Limited, Commonwealth Bank of Australia, National Australia Bank Limited and Westpac Banking Corporation (who will also act as Agent). Australia and New Zealand Banking Group acted as Documentation and Co-Ordination Bank.

The syndicated debt facility is split into two tranches, with $200 million maturing in September 2009 and $300 million maturing September 2011.

Sigma’s CEO, Elmo de Alwis, said that the refinance of all facilities has ensured sufficient debt facilities are available to fund ongoing operations, whilst maintaining flexibility.

“This refinance will mitigate Sigma’s refinance risk. Along with the recent re-introduction of a Dividend Reinvestment Plan for shareholders, this further demonstrates our ongoing focus on capital management,” Mr de Alwis said.

He went on to say “In the current credit environment, this is a particularly pleasing result, and the continued support of our banking group confirms their confidence in Sigma’s strategy.”

- End -